MEK Inhibitors
from Journal of Clinical Oncology (JCO) Podcast
The term targeted therapy is often used in cancer drug development. This podcast will discuss the study of a mEK inhibitor where the investigators actually looked at the impact on the target as well as whether the drug worked or did not work.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of Journal of Clinical Oncology (JCO) Podcast?
This episode is 6 minutes long.
When was this Journal of Clinical Oncology (JCO) Podcast episode published?
This episode was published on May 16, 2011.
Can I download this Journal of Clinical Oncology (JCO) Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.